Dr. Stephan's research focuses on population genetics and methods to accelerate the translation of new discoveries into clinical practice. His work moves research findings on the causes of human diseases into diagnostic tests to identify those diseases early, often before they strike, in order to help physicians and patients make better decisions.
In addition to diagnostics developments, Dr. Stephan's therapeutic development programs have resulted in the first human trials for a number of new and effective therapies, including drugs for diseases of the brain, such as autism spectrum disorder, amyotrophic lateral sclerosis Lou Gehrig's disease), and pediatric and adult cancers.
Dr. Stephan returned to Pittsburgh from San Francisco, where he most recently was the founder, president and chief executive officer of Silicon Valley Biosystems, a diagnostics company dedicated to helping physicians improve patient health and outcomes through an understanding of the human genome.
Dr. Stephan holds a Ph.D. in human genetics from the University of Pittsburgh.